Abstract
The study of biodistribution and pharmacokinetics of nanosystems devoted to biomedical applications is mandatory, especially for nanodevices with potential applications as agents for targeted drug delivery. The physicochemical properties of silica coated magnetic nanoparticles such as composition, size, and surface charge play important roles in the biological impact of the nanosystems. The biodistribution pattern of the nanoparticles gives information about those organs which are feasible for target and also provides information to develop new strategies to improve targeting. Pharmacokinetics and metabolism are two important issues in terms of the behavior of the magnetic nanoparticles in the organism to ensure a good combination between nanoparticles and specific drugs to treat the desired pathologies.
This chapter reviews the biodistribution, pharmacokinetics, and metabolism of silica, iron oxide nanoparticles, and silica-coated magnetic nanoparticles in order to understand the role of each component in the biological features proposed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Muthusamy, B., Hanumanthu, G., Suresh, S., Rekha, B., Srinivas, D., Karthick, L., et al. (2005). Plasma Proteome Database as a resource for proteomics research. Proteomics, 5(13), 3531–3536.
Lynch, I., & Dawson, K. A. (2008). Protein-nanoparticle interactions. Nano Today, 3(1), 40–47.
Aggarwal, P., Hall, J. B., McLeland, C. B., Dobrovolskaia, M. A., & McNeil, S. E. (2009). Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Advanced Drug Delivery Reviews, 61(6), 428–437.
Gessner, A., Lieske, A., Paulke, B. R., & Müller, R. H. (2002). Influence of surface charge density on protein adsorption on polymeric nanoparticles: Analysis by two-dimensional electrophoresis. European Journal of Pharmaceutics and Biopharmaceutics, 54(2), 165–170.
Monopoli, M. P., Walczyk, D., Campbell, A., Elia, G., Lynch, I., Baldelli Bombelli, F., et al. (2011). Physical − chemical aspects of protein corona: Relevance to in vitro and in vivo biological impacts of nanoparticles. Journal of the American Chemical Society, 133(8), 2525–2534.
Mahmoudi, M., Lynch, I., Ejtehadi, M. R., Monopoli, M. P., Bombelli, F. B., & Laurent, S. (2011). Protein − nanoparticle interactions: Opportunities and challenges. Chemical Reviews, 111(9), 5610–5637.
Deng, Z. J., Mortimer, G., Schiller, T., Musumeci, A., Martin, D., & Minchin, R. F. (2009). Differential plasma protein binding to metal oxide nanoparticles. Nanotechnology, 20(45), 455101.
Lesniak, A., Fenaroli, F., Monopoli, M. P., Åberg, C., Dawson, K. A., & Salvati, A. (2012). Effects of the presence or absence of a protein corona on silica nanoparticle uptake and impact on cells. ACS Nano, 6(7), 5845–5857.
Li, S. D., & Huang, L. (2008). Pharmacokinetics and biodistribution of nanoparticles. Molecular Pharmaceutics, 5(4), 496–504.
Opanasopit, P., Nishikawa, M., & Hashida, M. (2002). Factors affecting drug and gene delivery: Effects of interaction with blood components. Critical Reviews in Therapeutic Drug Carrier Systems, 19, 191–233.
Xie, G., Sun, J., Zhong, G., Shi, L., & Zhang, D. (2010). Biodistribution and toxicity of intravenously administered silica nanoparticles in mice. Archives of Toxicology, 84(3), 183–190.
Chithrani, B. D., Ghazani, A. A., & Chan, W. C. (2006). Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Letters, 6, 662–668.
Gao, H., Shi, W., & Freund, L. B. (2005). Mechanics of receptor-mediated endocytosis. Proceedings of the National Academy of Sciences of the United States of America, 102, 9469–9474.
He, X., Nie, H., Wang, K., Tan, W., Wu, X., & Zhang, P. (2008). In vivo study of biodistribution and urinary excretion of surface-modified silica nanoparticles. Analytical Chemistry, 80(24), 9597–9603.
Cho, M., Cho, W. S., Choi, M., Kim, S. J., Han, B. S., Kim, S. H., et al. (2009). The impact of size on tissue distribution and elimination by single intravenous injection of silica nanoparticles. Toxicology Letters, 189(3), 177–183.
Yu, T., Hubbard, D., Ray, A., & Ghandehari, H. (2012). In vivo biodistribution and pharmacokinetics of silica nanoparticles as a function of geometry, porosity and surface characteristics. Journal of Controlled Release, 163(1), 46–54.
Yoon, T. J., Yu, K. N., Kim, E., Kim, J. S., Kim, B. G., Yun, S. H., et al. (2006). Specific targeting, cell sorting, and bioimaging with smart magnetic silica core–shell nanomaterials. Small, 2(2), 209–215.
Barbe, C., Bartlett, J., Kong, L., Finnie, K., Lin, H. Q., Larkin, M., et al. (2004). Silica particles: A novel drug‐delivery system. Advanced Materials, 16(21), 1959–1966.
Li, Z. Z., Wen, L. X., Shao, L., & Chen, J. F. (2004). Fabrication of porous hollow silica nanoparticles and their applications in drug release control. Journal of Controlled Release, 98(2), 245–254.
Mader, H., Li, X., Saleh, S., Link, M., Kele, P., & Wolfbeis, O. S. (2008). Fluorescent silica nanoparticles. Annals of the New York Academy of Sciences, 1130(1), 218–223.
Zhao, X., Wang, J., Tao, S., Ye, T., Kong, X., & Ren, L. (2016). In vivo bio-distribution and efficient tumor targeting of gelatin/silica nanoparticles for gene delivery. Nanoscale Research Letters, 11(1), 1–9.
Huang, X., Li, L., Liu, T., Hao, N., Liu, H., Chen, D., et al. (2011). The shape effect of mesoporous silica nanoparticles on biodistribution, clearance, and biocompatibility in vivo. ACS Nano, 5(7), 5390–5399.
Andrews, N. C. (1999). Disorders of iron metabolism. New England Journal of Medicine, 341(26), 1986–1995.
Gutiérrez, L., Mejías, R., Barber, D. F., Veintemillas-Verdaguer, S., Serna, C. J., Lázaro, F. J., et al. (2011). Ac magnetic susceptibility study of in vivo nanoparticle biodistribution. Journal of Physics D: Applied Physics, 44(25), 255002.
Zysler, R. D., Lima, E., Jr., Mansilla, M. V., Troiani, H. E., Pisciotti, M. L., Gurman, P., et al. (2013). A new quantitative method to determine the uptake of SPIONs in animal tissue and its application to determine the quantity of nanoparticles in the liver and lung of Balb-c mice exposed to the SPIONs. Journal of Biomedical Nanotechnology, 9(1), 142–145.
Ruiz, A., Hernandez, Y., Cabal, C., González, E., Veintemillas-Verdaguer, S., Martinez, E., et al. (2013). Biodistribution and pharmacokinetics of uniform magnetite nanoparticles chemically modified with polyethylene glycol. Nanoscale, 5(23), 11400–11408.
Levy, M., Luciani, N., Alloyeau, D., Elgrabli, D., Deveaux, V., Pechoux, C., et al. (2011). Long term in vivo biotransformation of iron oxide nanoparticles. Biomaterials, 32(16), 3988–3999.
Kim, J. S., Yoon, T. J., Yu, K. N., Kim, B. G., Park, S. J., Kim, H. W., et al. (2006). Toxicity and tissue distribution of magnetic nanoparticles in mice. Toxicological Sciences, 89(1), 338–347.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2017 The Author(s)
About this chapter
Cite this chapter
Agotegaray, M.A., Lassalle, V.L. (2017). Biomedical Features. In: Silica-coated Magnetic Nanoparticles. SpringerBriefs in Molecular Science. Springer, Cham. https://doi.org/10.1007/978-3-319-50158-1_6
Download citation
DOI: https://doi.org/10.1007/978-3-319-50158-1_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-50157-4
Online ISBN: 978-3-319-50158-1
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)